Loading...
Market
Which region will be the next to approve MVA-BN vaccine for emergency use?
2
Resolution / Starting Odds
North America • 25%
Europe • 25%
Asia • 25%
Other • 25%
Official announcements from relevant regional health authorities
Story
WHO Prequalifies Bavarian Nordic's MVA-BN Vaccine as First Mpox Shot on Friday, Approved in Mexico
Sep 13, 2024, 09:45 AM
The World Health Organization (WHO) has prequalified the MVA-BN vaccine, developed by Bavarian Nordic, as the first vaccine against mpox. This approval, announced on Friday, marks a significant step towards expanding access and reducing transmission in high-risk communities. Additionally, the vaccine has been approved for emergency use in Mexico by Cofepris.
View original story
Similar markets
Kenya • 25%
Nigeria • 25%
South Africa • 25%
Other • 25%
Africa • 25%
Asia • 25%
Latin America • 25%
Other • 25%
United States • 25%
European Union • 25%
India • 25%
Other • 25%
United States • 25%
European Union • 25%
Africa • 25%
Other • 25%
Pfizer • 25%
Moderna • 25%
Johnson & Johnson • 25%
Other • 25%
United States • 25%
European Union • 25%
Japan • 25%
Other • 25%
United States • 25%
United Kingdom • 25%
Australia • 25%
Other • 25%
United States • 25%
European Union • 25%
China • 25%
Other • 25%
United States • 25%
United Kingdom • 25%
Canada • 25%
Australia • 25%
Argentina • 25%
Mexico • 25%
India • 25%
Other • 25%
Africa • 25%
Asia • 25%
Latin America • 25%
Other • 25%